FDA Approves Pertuzumab for Advanced, Her2+ Breast Cancer
My opinion is not quite formed on this new antibody. The FDA’s decision was based on results of one trial of 808 patients, half of whom didn’t get the experimental drug…
Learning From the San Antonio Breast Cancer Symposium, At a Distance
There’s a ton of BC and women’s health news this week. But yours truly is, among other things, not in San Antonio where is the 34th annual San Antonio Breast Cancer Symposium. NTW, quite a few major news outlets are covering this business closely and carefully, as are some bloggers I know. Upon reading the […]